• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, November 19, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Registry Analysis Identifies Key Factors Linked to CD4 Changes in HIV

by
November 19, 2026
in Health
Reading Time: 3 mins read
0
Registry Analysis Identifies Key Factors Linked to CD4 Changes in HIV

Registry Analysis Identifies Key Factors Linked to CD4 Changes in HIV

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

In a longitudinal cohort analysis of registry surveillance data from Isfahan, Iran, researchers evaluated post-baseline CD4 cell count dynamics across successive clinical visits among people living with HIV. The study analyzed how demographic characteristics, clinical status, treatment policies, and routine monitoring intervals related to overall immune measurements over time. By modeling repeated measurements recorded during routine medical care, the investigators identified distinct patient characteristics associated with post-baseline CD4 levels and examined whether broader policy shifts corresponded with measurable gains in CD4 counts.

The study cohort was drawn from a surveillance registry of 972 people living with HIV registered in Isfahan. To perform a robust mixed-effects analysis, researchers identified 642 patients who had an initial baseline CD4 record, at least one post-baseline follow-up CD4 measurement, and complete information across primary model covariates. Baseline CD4 was established as the patient’s first valid recorded measurement and was incorporated as an adjustment covariate to reflect starting immune status. Across the analytic sample, the longitudinal dataset comprised a total of 5,850 post-baseline CD4 measurements collected during routine healthcare delivery.

To account for the nature of registry surveillance, the investigators utilized the ordered sequence of observed post-baseline CD4 visits as the primary time scale rather than elapsed calendar time. Because routine CD4 testing in real-world clinical care often takes place at irregular, clinically driven intervals, the authors noted that slope estimates from the primary model reflect changes across successive test events rather than standard monthly or annual biological CD4 trajectories. The analytical approach utilized linear mixed-effects models equipped with random intercepts and random slopes, adjusting for patient demographics, clinical characteristics, antiretroviral therapy status, Treat-for-All policy status, diagnosis calendar year, and visit-frequency patterns.

In the fully adjusted multivariable model, older age and an AIDS classification at diagnosis were significantly associated with lower post-baseline CD4 levels. Conversely, individuals diagnosed in more recent calendar years and those entering care with higher baseline CD4 categories maintained higher post-baseline CD4 counts. Mode of transmission was also linked to immune status differences, with sexual transmission associated with higher CD4 levels relative to transmission via injecting drug use.

When evaluating the influence of national treatment policy frameworks, the investigators examined whether Treat-for-All status altered the rate of CD4 change across successive measurements. After adjusting for the patient’s diagnosis year, the analysis revealed no statistically detectable interaction between Treat-for-All status and CD4 change across ordered visits, yielding an interaction coefficient of negative 8.11 with a 95 percent confidence interval ranging from negative 32.18 to 15.95 and a p-value of 0.508. This indicated that policy-era classification alone did not explain trajectory slopes once secular calendar trends were taken into account.

The researchers also evaluated how observed visit regularity related to CD4 measurement slopes. In the primary mixed-effects model, maintaining regular visit intervals was associated with a lower CD4 increase across ordered measurements when compared with frequent visits, showing an interaction coefficient of negative 17.01 with a 95 percent confidence interval from negative 24.62 to negative 9.40 and a p-value below 0.001. In contrast, the interaction term comparing infrequent visit intervals with frequent visits did not demonstrate a statistically significant difference.

To assess the stability of these findings, the team conducted several sensitivity analyses, including date-linked elapsed-time models, nonlinear time specifications, evaluations excluding records with unknown Treat-for-All status, and early-monitoring models. Date-linked elapsed-time analyses supported the primary conclusions regarding Treat-for-All status and diagnosis year. However, estimates related to visit frequency exhibited sensitivity to the chosen time-scale structure and definitions of early monitoring, underscoring that visit-frequency patterns require nuanced interpretation.

The study authors highlighted critical methodological considerations when interpreting registry-based surveillance findings. Treat-for-All status functioned as a marker of a broader policy era rather than a direct, causal treatment intervention, as its rollout coincided with concurrent improvements in diagnostic practices, expanded antiretroviral drug access, registry completeness, and changes in monitoring protocols. Furthermore, because visit frequencies were derived from observational records, they likely capture care engagement, clinical visit scheduling, disease severity, and informative observation rather than isolated biological trajectories.

Subject of Research: Post-baseline CD4 patterns among people living with HIV in Isfahan, Iran

Article Title: Post-baseline CD4 patterns across successive measurements among people living with HIV in Isfahan, Iran: a registry-based longitudinal mixed-effects analysis

Article References: Nejat, M., Mansourian, M., Nasirian, M., Nobari, R. F., Hajari, A., & Tarrahi, M. J. (2026). Post-baseline CD4 patterns across successive measurements among people living with HIV in Isfahan, Iran: a registry-based longitudinal mixed-effects analysis. BMC Infectious Diseases. https://doi.org/10.1186/s12879-026-14430-z

Image Credits: AI Generated

DOI: 10.1186/s12879-026-14430-z

Keywords: HIV, CD4 count, longitudinal cohort study, mixed-effects models, Isfahan, Iran, Treat-for-All, disease registry, antiretroviral therapy, surveillance data, clinical staging, visit frequency, injecting drug use, sexual transmission, epidemiology, immune monitoring

News Source: Phoebe Ingram. (November 19, 2026). Registry Analysis Identifies Key Factors Linked to CD4 Changes in HIV. Scienmag.

Tags: antiretroviral therapyCD4 countclinical stagingdisease registryEpidemiologyHivimmune monitoringinjecting drug useIranIsfahanLongitudinal cohort studymixed-effects modelssexual transmissionsurveillance dataTreat-for-Allvisit frequency
Share12Tweet7Share2ShareShareShare1

Related Posts

Multidrug-Resistant Providencia hangzhouensis Strain Identified in Laying Hen Feces

Multidrug-Resistant Providencia hangzhouensis Strain Identified in Laying Hen Feces

November 19, 2026
Livestock Management and Soil Handling Drive Anthrax Outbreaks in Bangladesh

Livestock Management and Soil Handling Drive Anthrax Outbreaks in Bangladesh

November 19, 2026

Updated Kidney Injury Thresholds Identify More Children at High Mortality Risk

November 19, 2026

Deep Learning Architecture Accurately Detects Gym Posture Errors in Real Time

November 19, 2026

POPULAR NEWS

  • Study Reveals Outflow of Early-Career Japanese Pharmacists From Hospitals to Pharmacies

    Study Reveals Outflow of Early-Career Japanese Pharmacists From Hospitals to Pharmacies

    29 shares
    Share 12 Tweet 7
  • Mouse and Human Studies Show GATA2 Actively Maintains Müllerian Ducts

    29 shares
    Share 12 Tweet 7
  • Study Identifies Factors Linked to Women’s Health Decision Autonomy in Zambia

    29 shares
    Share 12 Tweet 7
  • Dual-Network Decomposition Model Improves Carbon Price Prediction Intervals Across Chinese Markets

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Multidrug-Resistant Providencia hangzhouensis Strain Identified in Laying Hen Feces

Livestock Management and Soil Handling Drive Anthrax Outbreaks in Bangladesh

Updated Kidney Injury Thresholds Identify More Children at High Mortality Risk

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.